Bandingkan Harga & Kinerja Palma Serasih Tbk. (PSGO) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Palma Serasih Tbk. dan Organon Pharma Indonesia Tbk.: Palma Serasih Tbk. diperdagangkan di Rp193 (kapitalisasi pasar 3,66 T, volume 24 jam 310,3 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Palma Serasih Tbk. jauh lebih besar — sekitar 35,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PSGO | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 3,66 T | 104,4 M |
Volume | 310,3 rb | — |
Lot | 3,1 rb | — |
Perputaran | 60,1 jt | — |
Harga Rata-rata | 193,68 | — |
Nilai Transaksi | 60,1 jt | — |
Harga Ekuilibrium Indikatif | 193 | — |
Volume Ekuilibrium Indikatif | 200 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Palma Serasih Tbk.
PT. Palma Serasih Tbk (the Company) was established in Jakarta based on Notarial Deed of Besri Zakaria,S.H. No.1 dated June 3, 2008. PT Jalinan kasih Sesama is the parent entity and the ultimate parent entity of the Group.
Selengkapnya di halaman PSGO →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
